A6-06: Integrative genomic and gene expression analysis of NSCLC identifies subtype-specific signatures of pathway disruption
William W. Lockwood(University of British Columbia), Wan L. Lam(University of British Columbia), John C. English(University of British Columbia Hospital), Bradley P. Coe, Raj Chari(National Institutes of Health), Ming‐Sound Tsao(Kumamoto University), Timon P.H. Buys(University of British Columbia), Stephen Lam(University of British Columbia), John Yee(BC Cancer Agency), Calum MacAulay(BC Cancer Agency)
Cited by 0
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
|New England Journal of Medicine|2013|1.4k
Near‐infrared Raman spectroscopy for optical diagnosis of lung cancer
|International Journal of Cancer|2003|811